{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:23Z","timestamp":1788922163636,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA042985"],"award-info":[{"award-number":["R01-DA042985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA14211"],"award-info":[{"award-number":["R01-DA14211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24-DA00417"],"award-info":[{"award-number":["K24-DA00417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR000448"],"award-info":[{"award-number":["UL1-TR000448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bja.2024.08.042","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:33:51Z","timestamp":1732584831000},"page":"358-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Morphine and hydromorphone pharmacokinetics in human volunteers: population-based modelling of interindividual and opioid-related variability"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-5453","authenticated-orcid":false,"given":"Konrad","family":"Meissner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Olofsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-3945","authenticated-orcid":false,"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-922X","authenticated-orcid":false,"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2024.08.042_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2009.02.002","article-title":"Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial","volume":"7","author":"Chang","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.bja.2024.08.042_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.annemergmed.2006.03.005","article-title":"Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial","volume":"48","author":"Chang","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.bja.2024.08.042_bib3","first-page":"e538","article-title":"Comparative efficacy of opioids for older adults presenting to the emergency department with acute pain: systematic review","volume":"65","author":"de Vries","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.bja.2024.08.042_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000004567","article-title":"Morphine and hydromorphone effects, side effects, and variability: a crossover study in human volunteers","volume":"139","author":"Meissner","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1213\/ANE.0000000000001534","article-title":"Long-acting patient-controlled opioids are not associated with more postoperative hypoxemia than short-acting patient-controlled opioids after noncardiac surgery: a cohort analysis","volume":"123","author":"Belcher","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/archdischild-2020-319059","article-title":"Morphine or hydromorphone: which should be preferred? A systematic review","volume":"106","author":"Spenard","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bja.2024.08.042_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/bja\/aer232","article-title":"Comparative clinical effects of hydromorphone and morphine: a meta-analysis","volume":"107","author":"Felden","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.08.042_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1213\/ANE.0000000000004788","article-title":"Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial","volume":"131","author":"Khanna","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2021.110167","article-title":"Postoperative opioid administration characteristics associated with opioid-induced respiratory depression: results from the PRODIGY trial","volume":"70","author":"Urman","year":"2021","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bja.2024.08.042_bib10","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1213\/ANE.0000000000005413","article-title":"Opioid-induced respiratory depression: is hydromorphone safer than morphine?","volume":"132","author":"Roth","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/psp4.12144","article-title":"Characterization of contributing factors to variability in morphine clearance through PBPK modeling implemented with OCT1 transporter","volume":"6","author":"Emoto","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.bja.2024.08.042_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/0091270008314465","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model","volume":"48","author":"Staahl","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bja.2024.08.042_bib13","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jcph.1400","article-title":"Integrated model to describe morphine pharmacokinetics in humans","volume":"59","author":"Liu","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bja.2024.08.042_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-7843.2011.00814.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview","volume":"110","author":"Ing Lorenzini","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2024.08.042_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-200411000-00021","article-title":"Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion","volume":"101","author":"Dahan","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib16","doi-asserted-by":"crossref","first-page":"e1008786","DOI":"10.1371\/journal.pcbi.1008786","article-title":"Physiologically based pharmacokinetic\/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children","volume":"17","author":"Verscheijden","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.bja.2024.08.042_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13318-015-0318-x","article-title":"External validation of a recently developed population pharmacokinetic model for hydromorphone during postoperative pain therapy","volume":"42","author":"Ihmsen","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bja.2024.08.042_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0b013e3182a76d05","article-title":"Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy","volume":"120","author":"Jeleazcov","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejps.2016.12.039","article-title":"Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics","volume":"99","author":"Nielsen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bja.2024.08.042_bib20","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic-pharmacodynamic modeling of opioids","volume":"29","author":"Lotsch","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.bja.2024.08.042_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-012-9282-0","article-title":"Translational PK-PD modeling in pain","volume":"40","author":"Yassen","year":"2013","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2024.08.042_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","article-title":"Likelihood based approaches to handling data below the quantification limit using NONMEM VI","volume":"35","author":"Ahn","year":"2008","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2024.08.042_bib23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2024.08.042_bib24","first-page":"77","article-title":"Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in male and female subjects","volume":"44","author":"Durnin","year":"2001","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.bja.2024.08.042_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bod.2510090207","article-title":"Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects","volume":"9","author":"Parab","year":"1988","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.bja.2024.08.042_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1155\/1996\/313012","article-title":"Analgesic and nonanalgesic effects of intravenous hydromorphone - relation to plasma concentrations in healthy volunteers","volume":"1","author":"Westerling","year":"1996","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.bja.2024.08.042_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1213\/00000539-199103000-00009","article-title":"Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects","volume":"72","author":"Hill","year":"1991","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/pan.13975","article-title":"Hydromorphone population pharmacokinetics in pediatric surgical patients","volume":"30","author":"Balyan","year":"2020","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.bja.2024.08.042_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1213\/ANE.0000000000005229","article-title":"Rifampin reduces the plasma concentrations of oral and intravenous hydromorphone in healthy volunteers","volume":"133","author":"Lohela","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007691-199506000-00013","article-title":"Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: relationship to nonanalgesic actions","volume":"17","author":"Westerling","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bja.2024.08.042_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.1993.127","article-title":"The pharmacokinetics of morphine and morphine glucuronides in kidney failure","volume":"54","author":"Osborne","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2024.08.042_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mcp.2002.126172","article-title":"Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers","volume":"72","author":"Lotsch","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2024.08.042_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s40262-017-0544-2","article-title":"Influence of morbid obesity on the pharmacokinetics of morphine, morphine-3-glucuronide, and morphine-6-glucuronide","volume":"56","author":"de Hoogd","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2024.08.042_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased mu-receptor agonist oliceridine versus morphine","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1213\/01.ane.0000265557.73688.32","article-title":"Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites","volume":"105","author":"Mazoit","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.08.042_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000542-200011000-00018","article-title":"Sex differences in morphine analgesia: an experimental study in healthy volunteers","volume":"93","author":"Sarton","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejps.2011.11.007","article-title":"Lipophilicity of morphine microspecies and their contribution to the lipophilicity profile","volume":"45","author":"Mazak","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bja.2024.08.042_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00003088-199324050-00005","article-title":"Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine","volume":"24","author":"Somogyi","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2024.08.042_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers","volume":"60","author":"Lotsch","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2024.08.042_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/psp4.12735","article-title":"Pharmacokinetic modeling of morphine and its glucuronides: comparison of nebulization versus intravenous route in healthy volunteers","volume":"11","author":"Duflot","year":"2022","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.bja.2024.08.042_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/00912700222011508","article-title":"Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers","volume":"42","author":"Murthy","year":"2002","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bja.2024.08.042_bib42","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000542-200310000-00008","article-title":"Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers","volume":"99","author":"Romberg","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200401000-00021","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences","volume":"100","author":"Romberg","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.08.042_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pbb.2009.06.016","article-title":"Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration","volume":"93","author":"Hemstapat","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bja.2024.08.042_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0024-3205(98)00288-4","article-title":"Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation","volume":"63","author":"Wright","year":"1998","journal-title":"Life Sci"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224006184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224006184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:56:17Z","timestamp":1769907377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091224006184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0007091224006184"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2024.08.042","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine and hydromorphone pharmacokinetics in human volunteers: population-based modelling of interindividual and opioid-related variability","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2024.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}